Complement depletion improves neurological function in cerebral ischemia

Brain Research Bulletin

Volumn 45, Issue 4, 1998, Pages 413-419

  Vasthare, U S ^a   Barone, F C ^b   Sarau, H M ^b   Rosenwasser, R H ^a   DiMartino, M ^b   Young, William F ^a   Tuma, Ronald F ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cobra venom factor; Complement system; Evoked potentials; Myeloperoxidase; Neutrophils; Transient forebrain ischemia

Indexed keywords

COBROTOXIN; LEUKOTRIENE B4; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL INFILTRATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; HYPEREMIA; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; COBRA VENOMS; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT SYSTEM PROTEINS; EVOKED POTENTIALS, SOMATOSENSORY; HEMOLYSIS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LEUKOTRIENE B4; VASCULAR RESISTANCE;

EID: 0032030974     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00408-5     Document Type: Article

References (57)

1. Barone F. C., Hillegass L. M., Price W. J., White R. F., Lee E. V., Feuerstein G. Z., Sarau H. M., Clark R. K., Griswold D. E. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue Myeloperoxidase activity assay and histologic verification . J. Neurosci. Res. 29:1991;336-345.
2. 4 receptor binding in rat focal ischemia. Stroke. 23:1992;1337-1348.
3. 4, a monoclonal antibody against the CD18 leukocyte adhesion protein, reduces intracranial pressure following thromboembolic stroke in the rat. Neurol. Res. 18:1996;171-175.
4. Bednar M. M., Raymond S., McAuliffe T., Lodge P. A., Gross C. E. The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. Stroke. 22:1991;44-50.
5. Bowes M. P., Zivin J. A., Rothlein R. Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp. Neurol. 119:1993;215-219.
6. Bradley P. P., Priebat D. A., Christensen R. D., Rothstein G. Measurement of cutaneous inflammation Estimation of neutrophil content with any enzyme marker . J. Invest. Dermatol. 78:1982;206-209.
7. Cattell V. Focal mesangial proliferative glomerularnephritis in the rat caused by Habu snake venom the role of platelets . Br. J. Exp. Pathol. 60:1979;201-218.
8. Chen H., Chopp M., Bodzin G. Neutropenia reduces the volume of cerebral infarct after transient middle cerebral artery occlusion in the rat. Neurosci. Res. Commun. 11:1992;93-99.
9. Clark R. K., Lee E. V., Fish C. J., White R. F., Price W. J., Jonak Z. L., Feuerstein G. Z., Barone F. C. Development of tissue damage inflammation and resolution following stroke An immunohistochemical and quantitative planimetric study . Brain Res. Bull. 31:1993;565-572.
10. Clark W. M., Madden K. P., Rothlein R., Zivin J. A. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecules. J. Neurosurg. 75:1991;623-627.
11. Cochrane C. G., Muller-Eberhard H. J., Aikon B. S. Depletion of plasma complement in vivo by a protein of cobra venom Its effect on various immunologic reactions . J. Immunol. 105:1970;55-69.
12. Dehring D. J., Steinberg S. M., Wismar B. L., Lowery B. D., Carey L. C., Cloutier C. T. Complement depletion in a porcine model of septic acute respiratory disease. J. Trauma. 27:1987;615-625.
13. del Zoppo G. J., Schmid-Schonbein G. N., Mori E., Copeland B. R., Chang C. M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 22:1991;1276-1283.
14. DiMartino M. J., Wolff C. E., Slivjak M. J., Minthorn E. A., Feuerstein G. Effects of soluble complement receptor (sCR-1, BRL 55730) on thermal skin injury induced hemoconcentration and lung inflammation in rats. Pharmacol. Commun. 3:1993;249-256.
15. Dutka A. J., Kochanek P. M., Hallenbeck J. M. Influence of granulocytopenia on canine cerebral ischemia induced by air embolism. Stroke. 20:1989;390-395.
16. Ernst E., Matrai A., Paulsen F. Leukocyte rheology in recent stroke. Stroke. 18:1987;59-62.
17. Gelfand J. A., Donelan M., Hawiger A., Burke J. F. Alternative complement pathway activation increases mortality in a model of burn injury in mice. J. Clin. Invest. 70:1982;1170-1176.
18. Gewurz H., Suyehira L. A. Complement. Rose N., Friedman R. H. American Manual of clinical immunology. 1976;36-47 Society of Microbiology, Washington, D.C.
19. Granger D. N., Kvietys P. R. Leukocyte-endothelial cell adhesion induced by ischemia and reperfusion. Can. J. Physiol. Pharmacol. 71:1993;67-75.
20. Grogaard B., Shurer L., Gudini B., Arfors K. E. Delayed hyoperfusion after incomplete forebrain ischemia in the rat The role of polymorphonuclear leukocytes . J. Cereb. Blood Flow Metab. 9:1989;500-505.
21. Hallenbeck J. M., Dutka A. J. Background review and current concepts of reperfusion injury. Arch. Neurol. 47:1990;1245-1254.
22. Hallenbeck J. M., Dutka A. J., Tanishima T., Kochanek P. M., Kumaroo K. K., Thompson C. B., Obrenovitch T. P., Conteros T. J. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke. 17:1986;246-253.
23. Harlan J. M. Neutrophil mediated vascular injury. Acta Med. Scand. 715:1987;1234-1249.
24. Heinel L. A., Vasthare U. S., Rosenwasser R. H., Tuma R. F. The effects of pentoxiphylline on recovery from cerebral ischemia and reperfusion injury. Hartmann A., Yatsu F., Kuschinsky W. Cerebral ischemia-basic mechanisms. 1994;421-429 Berlin, Heidelberg, Springer Verlag.
25. Heinel L. A., Rubin S., Rosenwasser R. H., Vasthare U. S., Tuma R. F. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Br. Res. Bull. 34:1994;137-141.
26. Kaczorowski S. L., Schiding J. K., Toth C. A., Kochanek P. M. Effect of complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 15:1995;860-864.
27. Luchessi B. R. Complement activation, neutrophils and oxygen radicals in reperfusion injury. Stroke Suppl. 24:1993;I41-I51.
28. Maroko P. R., Carpenter C. B., Chiarello M., Fishbein M. C., Radvany P., Knotsman J. D., Hale S. L. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J. Clin. Invest. 61:1978;661-670.
29. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninoniya M., Kihara T., Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Stroke. 25:1994;1469-1475.
30. Mayer, M. M. Complement and complement fixation. In: Kabar, E. A.; Thomas, C. C., eds. Experimental Cytochemistry. Springfield, IL, 1971:133-240.
31. Mayer M. M. The complement system. Sci. Am. 299:1973;54-66.
32. Mercuri M., Ciuffetti G., Robinson M., Toole J. Blood cell rheology in acute cerebral infarction. Stroke. 20:1989;959-962.
33. Mori E., del Zoppo G. J., Chambers J. D., Cope B. R., Arfors K. E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia. Stroke. 23:1992;712-718.
34. Muller-Eberhard H. J. Complement. Ann. Rev. Biochem. 44:1975;697-724.
35. Mulligan M. S., Yeh G. C., Rudolph A. R., Ward P. A. Protective effects of soluble CR1 in complement and neutrophil mediated tissue injury. J. Immunol. 148:1992;1479-1485.
36. Nelson R. A. A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity. Survey Ophtalmol. 11:1966;498.
37. Nordstrom C. H., Siesjo B. K. The effect of phenobarbital in cerebral ischemia Part I Cerebral energy metabolites during pronounced incomplete ischemia . Stroke. 9:1978;237-335.
38. Ostergaard J., Kristensen B., Svehag S. E., Teisner B., Miletec T. Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J. Neurosurg. 66:1987;891-897.
39. Pallettieri L., Carlsson C., Lindholm L. Is the vasospasm following subarachnoid hemorrhage an immunoreactive disease? Experientia. 37:1981;1170-1171.
40. Prentice R. L., Szatrowski T. P., Kato H., Mason M. W. Leukocyte counts and cerebrovascular disease. J. Chronic Dis. 35:1982;703-714.
41. Rabinovici R., Yeh C. G., Hillegass L. M., Griswold D. E., DiMartino M. J., Vernick J., Fong K-LL., Feuerstein G. The role of complement in endotoxin/PAF-induced lung injury. J. Immunol. 149:1992;1744-1750.
42. Rebhun J., Madorsky J., Glovsky M. Proteins of the complement system and acute phase reactants in sera of patients with spinal cord injury. Ann. Allergy. 60:1991;335-338.
43. 4 receptors on human monocytic leukemia U-937 cells. Adv. Prostaglandin Trhromboxane Leukot. Res. 19:1989;180-186.
44. Schurer L., Grogaard B., Gerdin B., Arfors K-E. Effects of neutrophil depletion and superoxide dismutase on postischemic hypoperfusion of rat brain. Adv. Neurol. 52:1990;57-62.
45. Shiga Y., Onodera H., Kyuya K., Yamasaki Y., Yashima Y. Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci. Lett. 125:1991;110-112.
46. Stevens J. H., O'Hanley P., Shapiro J. M., Mihm F. G., Satoh P. S., Collins J. A., Raffin T. A. Effects and anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J. Clin. Invest. 77:1986;1812-1816.
47. Till G. O., Beauchamp C., Menapace D., Tourtelotte W., Kunkel R., Johnson K. J., Ward P. A. Oxygen radical dependent lung damage following thermal injury of rat skin. J. Trauma. 28:1983;269-277.
48. Till G. O., Guilds L. S., Mahrougui M., Friedl H. P., Trentz O., Ward P. A. Role of xanthine oxidase in thermal injury of skin. Am. J. Pathol. 135:1986;195-202.
49. Tuma, R. F.; Vasthare, U. S.; Salehi, H. A.; Spera, P.; Rosenwasser, R. H. White cell involvement in cerebral ischemia and reperfusion injury. In: Tomita, M.; Mchedlishvilli, eds. Microcirculatory stasis on the brain, Elsevier Science Publishers Amsterdam. 1993:123-131.
50. Vasthare U. S., Rocco M. J., Carlsson C., Tuma R. F., Kaykah M., Harp J. R. Effect of fentanyl and nubain on regional cerebral blood flow. Fed. Proc. 46:1987;356.
51. Vasthare U. S., Heinel L. A., Rosenwasser R. H., Tuma R. F. Leukocyte involvement in cerebral ischemia in reperfusion injury. Surg. Neurol. 33:1990;261-265.
52. Vasthare U. S., Rubin S., Riina H., Rosenwasser R. H., Tuma R. F. Effect of fentanyl on the recovery following incomplete global cerebral ischemia. Drug Dev. Res. 23:1991;227-232.
53. Vermes I., Strile F. Altered leukocyte rheology in patients with chronic cerebrovasclar disease. Stroke. 19:1988;631-633.
54. Weisman H. F., Bertew T., Leppo M. K., Marsh H. C., Carson G. R., Concino M. F., Boyle M. P., Roux K. H., Weisfeldt M. L., Fearon D. T. Soluble human complement receptor type 1 in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis . Science. 249:1990;146-151.
55. 4-induced homologous desensitization of calcium mobilization and phosphoinositide metabolism in U-937 cells. J. Pharmacol. Exp. Ther. 246:1990;204-210.
56. Yamakawa T., Yamaguchi S., Niimi H., Sugiyama I. WBC plugging and cerebral blood flow maldistribution in the capillary network of cat cerebral cortex in acute hemorrhagic hypotension an intra-vital microscopic study . Circ. Shock. 22:1987;323-332.
57. Yeh C. G., Marsh H. C., Carson G. R., Berman L., Concino M. F., Scesney S. M., Kuestner R. E., Skibbens R., Donahue K. A., Ip S. H. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. J. Immunol. 146:1991;250-256.